Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the deadly
disease known as coronavirus disease 2019 (COVID-19) that has reached pandemic …

Introduction COVID-19 vaccines have been highly effective in reducing morbidity and
mortality during the pandemic. While primary series vaccination rates are generally high in …

Background There are few data on the incidence of thrombosis among COVID-19 cases,
with most research concentrated on hospitalised patients. We aimed to estimate the …

Organisation mondiale de la Santé 2022 Certains droits réservés. La présente œuvre est
disponible sous la licence Creative Commons Attribution Pas d'utilisation commerciale …

Abstract Background The Global COVID Vaccine Safety (GCoVS) Project, established in
2021 under the multinational Global Vaccine Data Network™(GVDN®), facilitates …

Importance Concerns have been raised that the use of antipsychotic medication for people
living with dementia might have increased during the COVID-19 pandemic. Objective To …

Since COVID-19 vaccine roll-out, very rare cases of thrombosis with thrombocytopenia
syndrome (TTS), which has been referred to as vaccine-induced immune thrombotic …

Prior to deployment of coronavirus disease 2019 (COVID‐19) vaccines in the European
Union in 2021, a high vaccine uptake leading to an unprecedented volume of safety data …

Objective The coronavirus disease 2019 (COVID-19) pandemic has demonstrated the value
of real-world data for public health research. International federated analyses are crucial for …

Abstract Background The Global COVID Vaccine Safety (GCoVS) project was established in
2021 under the multinational Global Vaccine Data Network (GVDN) consortium to facilitate …